EMERGENCE OF SARS 4. Cox E, Pensaert M, Hooyberghs J, Van Deun K. Sites of replication of porcine respiratory coronavirus in 5-week-old pigs with or without maternal antibodies. Adv Exp Med Biol 1990;276:429–33. 5. Beaty BJ, Calisher CH, Shope RS. Arboviruses. In: Schmidt NJ, Emmons RW, editors. Diagnostic procedures for viral, rickettsial and chlamydial infections. 6th ed. Washington: American Public Health Association; 1989. p. 797–856. 6. Lai MMC, Cavanagh D. The molecular biology of coronaviruses. Adv Virus Res 1997;48:1–100. 7. Sawicki SG, Sawicki DL. A new model for coronavirus transcription. Adv Exp Med Biol 1998;440:215–9. 8. Igarashi T, Brown C, Azadegan A, Haigwood N, Dimitrov D, Martin MA, et al. Human immunodeficiency virus type 1 neutralizing anti- bodies accelerate clearance of cell-free virions from blood plasma. Nat Med 1999;5:211–6. 9. Bernard KA, Klimstra WB, Johnston RE. Mutations of the E2 glyco- protein of Venezuelan equine encephalitis virus confer heparan sul- fate interaction, low morbidity, and rapid clearance from blood of mice. Virology 2000;276:93–103. 10. Have P. Infection with a new porcine respiratory coronavirus in Denmark: serologic differentiation from transmissible gastroenteritis virus using monoclonal antibodies. Adv Exp Med Biol 1990;276:435–9. 11. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syn- drome. N Engl J Med 2003;348:1953–66 Address for correspondence: Hana M. Weingartl, NCFAD, CFIA, 1015 Arlington St., Winnipeg, MB, R3E 3M4, Canada; fax: 204-789-2038; email: hweingartl@inspection.gc.ca Search past issues of EID at www.cdc.gov/eid 184 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 2, February 2004